Joshua D Milner Selected Research

Polyethylene Glycols (Polyethylene Glycol)

1/2021

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua D Milner Research Topics

Disease

10	Inflammation (Inflammations) 05/2024 - 10/2010
9	Infections 04/2024 - 04/2008
8	Atopic Dermatitis (Atopic Eczema) 06/2024 - 12/2013
8	Hypersensitivity (Allergy) 01/2023 - 04/2008
6	Job Syndrome (Hyper-IgE Syndrome) 01/2018 - 03/2010
5	Anaphylaxis (Anaphylactic Shock) 01/2021 - 05/2009
4	Asthma (Bronchial Asthma) 12/2023 - 07/2004
4	Hereditary alpha-tryptasemia syndrome 04/2022 - 06/2020
4	Food Hypersensitivity (Food Allergy) 01/2021 - 07/2004
4	Eczema 01/2020 - 12/2013
4	Eosinophilia 01/2019 - 01/2007
3	COVID-19 04/2024 - 10/2020
3	Neoplasms (Cancer) 12/2023 - 12/2022
3	Pneumonia (Pneumonitis) 01/2021 - 01/2007
3	Reinfection 01/2019 - 09/2017
3	Immune System Diseases (Immune Disorders) 01/2019 - 05/2013
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2019 - 11/2010
3	Immediate Hypersensitivity 01/2019 - 01/2016
3	Common Variable Immunodeficiency 01/2019 - 01/2012
3	Inborn Genetic Diseases (Disease, Hereditary) 09/2017 - 12/2011
2	Skin Diseases (Skin Disease) 09/2023 - 01/2021
2	Systemic Mastocytosis 01/2023 - 01/2021
2	Edema (Dropsy) 01/2023 - 01/2022
2	Bronchiolitis 10/2022 - 10/2012
2	Necrosis 01/2021 - 04/2008
2	Allergic Rhinitis 01/2021 - 01/2018
2	Autonomic Nervous System Diseases (Dysautonomia) 10/2019 - 12/2016
2	Lymphoma (Lymphomas) 01/2019 - 01/2018
2	Neutropenia 01/2019 - 10/2016
2	Acute-Phase Reaction 01/2019 - 09/2017
2	Dermatitis 01/2019 - 08/2015
2	Wiskott-Aldrich Syndrome 10/2016 - 08/2015
2	Severe combined immunodeficiency due to adenosine deaminase deficiency 08/2015 - 12/2013
2	Urticaria (Hives) 10/2012 - 05/2009
2	Exanthema (Rash) 01/2012 - 05/2009
1	Anemia 04/2024
1	Cold Urticaria 03/2024
1	Fatigue 02/2024
1	Chronic Urticaria 01/2024
1	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2023
1	Bacterial Infections (Bacterial Infection) 12/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2022
1	Respiratory Insufficiency (Respiratory Failure) 10/2022
1	Bites and Stings (Sting) 01/2021
1	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Leukemia 01/2021
1	Lipodystrophy 01/2021
1	deficiency of adenosine deaminase 2 01/2021
1	Mevalonate Kinase Deficiency 01/2021
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Familial Mediterranean Fever (Periodic Disease) 01/2021

Drug/Important Bio-Agent (IBA)

14	Immunoglobulin E (IgE)IBA 01/2021 - 05/2009
13	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2010
9	Tryptases (Tryptase)IBA 01/2023 - 12/2016
7	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019 - 06/2013
6	CytokinesIBA 05/2024 - 03/2010
4	AntigensIBA 12/2023 - 04/2008
3	VaccinesIBA 04/2024 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2015
3	Phospholipases (Phospholipase)IBA 09/2018 - 10/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 05/2013
2	ChromatinIBA 12/2023 - 01/2023
2	GadoliniumIBA 01/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 12/2022 - 01/2019
2	AllergensIBA 01/2021 - 10/2016
2	AntibodiesIBA 01/2021 - 01/2021
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 10/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2010
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2016 - 05/2009
2	AutoantibodiesIBA 10/2012 - 05/2009
2	Interleukin-17 (Interleukin 17)IBA 12/2011 - 04/2008
1	baricitinibIBA 06/2024
1	COVID-19 VaccinesIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	catechol (pyrocatechol)IBA 02/2024
1	Omalizumab (Xolair)FDA Link 01/2024
1	dupilumabIBA 01/2024
1	Janus Kinase InhibitorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	InterleukinsIBA 01/2023
1	TNF Receptor-Associated Factor 3IBA 12/2022
1	Nucleic AcidsIBA 01/2021
1	PolymersIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	veltuzumabIBA 01/2021
1	Lipid NanoparticlesIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	VenomsIBA 01/2021
1	Interferon Type IIBA 10/2020
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2020

Therapy/Procedure

2	Immunotherapy 12/2023 - 01/2019
2	Genomic Medicine 09/2023 - 10/2022
2	Therapeutics 01/2022 - 05/2009
1	Critical Care (Surgical Intensive Care) 04/2024